In this video, Dr Joshua Baker, an assistant professor of rheumatology and epidemiology at the University of Pennsylvania, discusses the risk of diabetes among patients with rheumatoid arthritis.
In this video, Dr Joshua Baker, an assistant professor of rheumatology and epidemiology at the University of Pennsylvania, discusses the risk of diabetes among patients with rheumatoid arthritis.
In this video, Leonard Calabrese, DO, and Cassandra Calabrese, DO, discuss their experiences with the COVID-19 pandemic, including the ongoing drug trials at the Cleveland Clinic. Read the transcript here.
Additional Resource:
In this video, Leonard Calabrese, DO, and Cassandra Calabrese, DO, discuss their experiences with the COVID-19 pandemic, including the ongoing drug trials at the Cleveland Clinic. Read the transcript here.
Additional Resource:
The American College of Rheumatology (ACR) guideline for the management of juvenile idiopathic arthritis (JIA) is currently under review and will soon be published. In this video, the lead investigator of the guideline’s Core Team, Karen...
The American College of Rheumatology (ACR) guideline for the management of juvenile idiopathic arthritis (JIA) is currently under review and will soon be published. In this video, the lead investigator of the guideline’s Core Team, Karen...
The US Food and Drug Administration (FDA) has approved Xeljanz (tofacitinib) for the treatment of active polyarticular course juvenile idiopathic arthritis (pcJIA) among pediatric patients aged 2 years or older.
The...
The US Food and Drug Administration (FDA) has approved Xeljanz (tofacitinib) for the treatment of active polyarticular course juvenile idiopathic arthritis (pcJIA) among pediatric patients aged 2 years or older.
The...
Patients with psoriasis who also have structural entheseal lesions, even when they have no clinical symptoms of musculoskeletal disease, are at a higher risk of developing psoriatic arthritis (PsA) than patients...
Patients with psoriasis who also have structural entheseal lesions, even when they have no clinical symptoms of musculoskeletal disease, are at a higher risk of developing psoriatic arthritis (PsA) than patients...
